SIBN - NASDAQ

SI-BONE, Inc.

SIBN·NASDAQ

$13.92

-0.64%

HealthcareMedical - Devices

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$617.34M

EPS-0.4400

P/E Ratio-31.64

Earnings Date08/03/2026

238.56M

Assets

3Y+51.0%

5Y+7.0%

10Y+505.0%

61.02M

Total Liabilities

-4%

3Y+3.0%

5Y+13.0%

10Y-59.0%

177.53M

Total Equity

3Y+81.0%

5Y+5.0%

10Y-263.0%

SI-BONE, Inc. Funding & Solvency Profile

SIBN · NASDAQ

Current Assets

Cash & Cash Equivalents42.24M

Net Receivables29.91M

Inventory33.90M

Other Current Assets4.48M

Total Current Assets216 M

Non-Current Assets

Property, Plant & Equipment22.39M

Goodwill & Intangible Assets0.00

Long-Term Investments0.00

Other Non-Current Assets55.00K

Total Non-Current Assets22 M

Total Assets

238.56M

Financial Health Analysis

Current Ratio

8.55x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.34x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

191 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

91% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

SI-BONE, Inc. Balance Sheet

SIBN • NASDAQ

SI-BONE, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	42.2M	34.9M	33.3M	20.7M	63.4M	53.6M	10.4M	25.1M	22.4M	27.9M	20.3M	17.6M	8.5M
Short-Term Investments	105.6M	115.1M	132.7M	76.6M	83.6M	142.9M	81.3M	97.1M	0.0	0.0	0.0	0.0	0.0
Cash & Short-Term Investments	147.8M	150M	166M	97.3M	147M	196.4M	91.8M	122.2M	22.4M	27.9M	20.3M	17.6M	8.5M
Net Receivables	29.9M	27.5M	22M	20.7M	14.2M	13.6M	11.7M	8.5M	7.4M	6M	5.8M	5.9M	6M
Accounts Receivables	29.9M	27.5M	22M	20.7M	14.2M	13.6M	11.7M	8.5M	7.4M	6M	5.8M	5.9M	6M
Inventory	33.9M	27.1M	20.2M	17.3M	11.5M	5.6M	5.5M	3.3M	2.6M	1.5M	2.7M	1.7M	1.3M
Prepaids	0.0	0.0	0.0	0.0	3.1M	2.6M	2.5M	2M	1.3M	959K	0.0	0.0	0.0
Other Current Assets	4.5M	3.2M	3.2M	2.4M	0.0	0.0	0.0	2M	0.0	0.0	1.2M	837K	655K
Total Current Assets	216.1M	207.8M	211.4M	137.6M	175.9M	218.2M	111.5M	136M	33.6M	36.3M	29.9M	26M	16.5M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	22.4M	22.4M	18.7M	19.6M	14.2M	4.5M	4M	2.2M	1.9M	2.6M	3.5M	2.6M	1.2M
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4M	47K	55K	62K	70K
Goodwill & Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40K	47K	55K	62K	70K
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	1.3M	0.0	0.0	521K	634K	0.0	0.0
Tax Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-521K	0.0	0.0	0.0
Other Non-Current Assets	55K	300K	325K	375K	400K	374K	315K	325K	269K	457K	1.9M	319K	274K
Total Non-Current Assets	22.4M	22.7M	19M	19.9M	14.6M	4.9M	5.5M	2.5M	2.2M	3.1M	6.2M	3M	1.5M
Total Assets	238.6M	230.4M	230.4M	157.6M	190.5M	223.1M	117M	138.5M	35.8M	39.4M	36.1M	29M	18M
LIABILITIES
CURRENT LIABILITIES
Total Payables	4.6M	6.5M	4.6M	6.3M	3.2M	3.3M	2.8M	2.5M	2.3M	1.5M	2.9M	2.9M	4.1M
Accounts Payable	4.6M	6.5M	4.6M	6.3M	3.2M	3.3M	2.8M	2.1M	1.8M	1M	2.5M	2.6M	3.7M
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	388K	466K	448K	423K	321K	329K
Accrued Expenses	0.0	4.6M	2.3M	1.2M	995K	511K	7.3M	914K	3.7M	614K	0.0	0.0	0.0
Short Term Debt	944K	0.0	0.0	0.0	0.0	0.0	4.4M	0.0	0.0	8.2M	0.0	0.0	2.2M
Capital Lease Obligations (Current)	0.0	1.2M	1.4M	1.4M	1.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	0.0	0.0	0.0	0.0	0.0	370K	388K	466K	448K	423K	0.0	0.0
Deferred Revenue	0.0	0.0	0.0	0.0	0.0	0.0	11.3M	0.0	0.0	3.9M	0.0	0.0	0.0
Other Current Liabilities	19.7M	14.9M	15.2M	12.3M	11.4M	9.7M	-7M	5.6M	1.5M	3.1M	4.3M	4.3M	4.2M
Total Current Liabilities	25.3M	27.1M	23.5M	21.2M	16.9M	13.5M	18.8M	9M	7.5M	13.4M	6.8M	6.9M	10.2M
NON-CURRENT LIABILITIES
Long Term Debt	175K	35.5M	36.1M	35.2M	35M	39.5M	34.9M	39M	38.7M	21.1M	25.1M	15.2M	9.5M
Other Non-Current Liabilities	35.6M	10K	18K	30K	57K	854K	362K	360K	119M	113.7M	957K	-15.2M	-9.5M
Total Non-Current Liabilities	35.7M	36.3M	37.6M	38.1M	39.2M	40.3M	35.2M	39.3M	157.7M	134.8M	26M	15.2M	9.5M
Capital Lease Obligations	0.0	2M	2.9M	4.3M	5.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	61M	63.5M	61.1M	59.3M	56.1M	53.8M	54M	48.3M	165.2M	148.2M	32.8M	22.1M	19.7M
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-9.9M	-8M	0.0	0.0	0.0
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	138.5M	118.5M	113.1M	92.8M	71.5M	36.4M
Common Stock	627M	4K	4K	3K	3K	3K	258.1M	3K	1K	1K	7K	5K	4K
Additional Paid-In Capital	0.0	598.1M	569.5M	455.2M	429.9M	408.1M	258.1M	246.9M	9.9M	8M	0.0	0.0	0.0
Retained Earnings	-450.3M	-431.4M	-400.4M	-357.1M	-295.8M	-239.3M	-195.6M	-157.2M	-139.7M	-116.7M	-96.1M	-67.9M	-40.1M
Accumulated Other Comprehensive Income/Loss	816K	244K	335K	232K	352K	524K	464K	439K	402K	472K	405K	-498K	-249K
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-118.5M	-113.6M	6.1M	3.8M	2.4M
Total Stockholders' Equity	177.5M	167M	169.4M	98.3M	134.4M	169.4M	63M	90.2M	-129.4M	-108.7M	3.2M	6.9M	-1.7M
Total Equity	177.5M	167M	169.4M	98.3M	134.4M	169.4M	63M	90.2M	-129.4M	-108.7M	3.2M	6.9M	-1.7M
SUMMARY
Total Liabilities & Equity	238.6M	230.4M	230.4M	157.6M	190.5M	223.1M	117M	138.5M	35.8M	39.4M	36.1M	29M	18M
Total Investments	105.6M	115.1M	132.7M	76.6M	83.6M	142.9M	82.6M	97.1M	0.0	521K	634K	0.0	0.0
Total Debt	1.1M	37.5M	39M	39.4M	40.5M	39.5M	39.2M	39M	38.7M	29.3M	25.1M	15.2M	11.7M
Net Debt	-41.1M	2.5M	5.7M	18.7M	-22.9M	-14.1M	28.8M	13.8M	16.3M	1.4M	4.8M	-2.4M	3.2M
Shares Outstanding	43,140,936	43,140,936	43,140,936	43,140,936	43,140,936	43,140,936	43,140,936	43,140,936	43,140,936	43,140,936	43,140,936	43,140,936	43,140,936

SEC Filings

SIBN - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 11, 2026	May 11, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 11, 2026	March 31, 2026	2026	View Filing
DEF 14A DEF 14A 2025 N/A	April 21, 2026	December 31, 2025	2025	View Filing
10-K 10-K 2025 FY FY	February 24, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 23, 2026	February 20, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 12, 2026	January 12, 2026	2026	View Filing
10-Q 10-Q 2025 Q3 Q3	November 10, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 10, 2025	November 06, 2025	2025	View Filing
10-Q 10-Q 2025 Q2 Q2	August 05, 2025	June 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	August 04, 2025	July 31, 2025	2025	View Filing

Showing 1 to 10 of 110 filings

Related Guides

Blog Categories

Continue your SIBN research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.